ACADIA Pharmaceuticals Inc.ACADNASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
12.26%
↑ 106% vs avg
Percentile
P100
Near historical high
Streak
3 yr
Consecutive growthExpanding
Average
-210.48%
Historical baseline
PeriodValueYoY Change
TTM12.26%+17.3%
202410.46%+212.0%
2023-9.34%+78.2%
2022-42.84%-24.1%
2021-34.51%+46.2%
2020-64.21%+10.7%
2019-71.90%+34.2%
2018-109.22%+52.9%
2017-231.94%+85.2%
2016-1563.60%-